Serum Institute may supply around 400 million more doses to Gavi-Covax

The world’s largest vaccine maker (by dosages), Serum Institute of India, is likely to finalise a deal with Gavi-Covax for supplying around 400 million doses of the Covid-19 vaccine in the next few weeks, according to sources. 

While Serum Institute did not wish to comment on the story, people in the know said talks were on to finalise a supply agreement for 300-400 million doses of the vaccine. 

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose. 

The Pune-based firm had also received risk funding of around $300